Natco Pharma's Canadian unit signs pact with Celgene for cancer treatment drug

Natco Pharma entered into an agreement with biopharmaceutical firm Celgene for Lenalidomide capsules, which is used to treat various types of cancers. It works by slowing or stopping the growth of cancer cells.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3iPEmMs
via IFTTT